19. February 2021 | Adhoc News

Marinomed Biotech AG shares positive clinical trial results for iota-carrageenan nasal spray in the prevention of COVID-19

Adhoc-Announcement

The full Adhoc announcement is available as download here:

Marinomed Biotech AG shares positive clinical trial results for iota-carrageenan nasal spray in the prevention of COVID-20
(147 KB)